Further supporting the notion that ACF reaches tumor cells are the quantitative real-time PCR analyses of tumor tissues that showed decreased expression of some HIF-1 targets indicating that ACF may effectively inhibit MCT4-Basigin interaction in vivo. Here, HIF1A is linked to neoplasm.